1. bookVolume 27 (2019): Issue 2 (December 2019)
Journal Details
First Published
08 Aug 2013
Publication timeframe
2 times per year
access type Open Access

The Relation of Omentin-1 Levels and Some Trace Elements as a Potential Markers for Diagnosis of Prediabetic Obese Patients

Published Online: 26 Dec 2019
Page range: 203 - 226
Journal Details
First Published
08 Aug 2013
Publication timeframe
2 times per year

The obesity is one of the most common physiological disorders, also it is linked with a variety of circumstances like hypertension, dyslipidemia, T2DM, non-alcoholic fatty liver disease, and cardiovascular diseases. The aim of this study was to check the changes and compare serum omentin-1, lipid profile (TC, TG, VLDL-C, LDL-C, and HDL-C), trace elements (Mg, Zn, Cu, Fe) and insulin resistance between the prediabetic obese patients, healthy obese, and control subjects and assess the correlation between omentin-1, lipid profile, trace elements (Mg, Zn, Cu, Fe) levels and insulin resistance in prediabetic obese patients. Correlation analysis between omentin-1 levels with the biochemical parameters in the prediabetic obese patients with WC, body mass index, FBG, Insulin, HOMA-IR, HbA1c, TG, TC, LDL-C, VLDL-C, and copper was found to be negative; while significant positive correlation of omentin-1 with HDL-C, Mg, Zn, and Fe was noticed. Omentin-1 serum concentration level decrease and insulin resistance increased in prediabetic obese patients compared to healthy obese and control individuals. Omentin-1 inversely associated with obesity and insulin resistance, therefore can be used as a biomarker for obesity related metabolic disorders.


1. Koborova, I.; Gurecka, R.; Hdavata, A.; Šebeková, K. Association between asymptomatic hyperuricaemia and metabolic syndrome in the adolescents. Vnitr. Lek. 2015, 61(1), 42-49.Search in Google Scholar

2. Wing, M.; Ziegler, J.; Langefeld, C.; Najim, C.; Haffner, S.; Norris, J.; Goodarzi, M.; Bowden, D.W. Analysis of FTO gene variants with measures of obesity and glucose homeostasis in the IRAS Family Study. Hum. Genet. 2009, 125, 615-626.Search in Google Scholar

3. American Diabetes Association. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2018. Diabetes Care,2018, 41, S13-S27.Search in Google Scholar

4. Labadzhyan, A.; Cui, J.; Peterfy, M.; Guo, X.; Chen, Y.; Hsueh, W.; Rotter, J.; Goodarzi, M. Insulin clearance is associated with hepatic lipase activity and lipid and adiposity traits in Mexican Americans. PLoS One,2016, 11(11), 166-263.Search in Google Scholar

5. Chou, P.; Liao, M.; Tsai, S. Associated risk factors for diabetes in kin-HU, kinmen. Diabetes Res. Clin. Pract.1994, 26(3), 229-235.Search in Google Scholar

6. Punthakee, Z.; Goldenberg, R. Diabetes Canada Clinical Practice Guidelines Expert Committee. Definition, Classification and Diagnosis of Diabetes, prediabetes and metabolic syndrome. Can. J. Diabetes, 2018, 42(1), S10-S15.Search in Google Scholar

7. Tahrani, A.; Barnett, A.; Bailey, C. Pharmacology and therapeutic implications of current drugs for type 2 diabetes mellitus. Nat. Rev. Endocrinol. 2016, 12(10), 566-592.Search in Google Scholar

8. Lago, F.; Gomez, R.; Gomez-Reino, J.; Dieguez C. Adipokines as novel modulators of lipid metabolism. Trends Biochem. Sci. 2009, 34(10), 500-510.Search in Google Scholar

9. De Souza Batista, C.; Yang, R.; Lee, M. Omentin plasma levels and gene expression are decreased in obesity. Diabetes2007, 56(6), 1655-1661.Search in Google Scholar

10. Tan, B.; Adya, R.; Farhatullah, S.; Chen, T. Metformin treatment may increase omentin-1 levels in women with polycystic ovary syndrome. Diabetes2010, 59(12), 3023-3031.Search in Google Scholar

11. Yamawaki, H.; Kuramoto, J.; Kameshima, S. Omentin a novel adipocytokine inhibits TNF-induced vascular inflammation in human endothelial cells. Biochem. Biophys. Res. Commun.2011, 408(2), 339-343.Search in Google Scholar

12. Duan, X.; Xie, P.; Ma, Y.; Tang, S. Omentin inhibits osteoblastic differentiation of calcifying vascular smooth muscle cells through the PI3K/AKT pathway. Amino Acids2011, 41(5), 1223-1231.Search in Google Scholar

13. Bergmann, K.; Sypniewska, G. Diabetes as a complication of adipose tissue dysfunction. Is there a role for potential new biomarkers? Clin. Chem. Lab. Med.2013, 51(1), 177-185.Search in Google Scholar

14. Aktas, G.; Alcelik, A.; Ozlu, T.; Tosun, M.; Tekce, B.; Savli, H.; Tekce, H.; Dikbas, O. Association between omentin levels and insulin resistance in pregnancy. Exp. Clin. Endoc. Diab. 2014, 122(3), 163-166.Search in Google Scholar

15. Zhang, X.; Zhang, H.; Tan, H.; Zhou, Y.; Liu, F. Association of serum omentin-1 levels with coronary artery disease. Acta Phermacol. Sin.2012, 32(7), 873-878.Search in Google Scholar

16. Choi, H.; Kim, S.; Yang, S.; Yoo, H.; Seo, J.; Kim, S.; Kim, N.; Baik, S.; Choi, D.; Choi, K. Association of adiponectin, resistin, and vascular inflammation: analysis with 18F-Fluorodeoxy glucose positron emission tomography. Arterioscler. Thromb. Vasc. Biol. 2011, 31(4), 944-949.Search in Google Scholar

17. Narumi, T.; Watanabe, T.; Kadowaki, S.; Kinoshita, D. Impact of serum omentin-1 levels on cardiac prognosis in patients with heart failure. Cardiovasc. Diabetol. 2014, 13, 13-20.Search in Google Scholar

18. Zhou, J.; Chan, L.; Zhou, S. Omentin: Linking metabolic syndrome and cardiovascular disease. Curr. Vasc. Pharmacol. 2014, 12(1), 136-143.Search in Google Scholar

19. Akour, A.; Kasabri, V.; Boulatova, N.; Bustanji, Y.; Naffa, R.; Hyasat, D.; Khawaja, N.; Bustanji, H.; Zayed, A.; Momani, M. Levels of metabolic markers in drug-naive prediabetic and type 2 diabetic patients. Acta Diabetol. 2017, 54(2), 163-170.Search in Google Scholar

20. Urbanova, M.; Dostaaova, I.; Trachta, P.; Drapalova, J.; Kavalkova, P.; Haluzikova, D.; Matoulek, M.; Lacinová, Z.; Mráz, M.; Kasalický, M.; Haluzík, M. Serum concentration and subcutaneous adipose tissue mRNA expression of omentin in morbid obesity and type II diabetes mellitus: the effect of very low-calorie diet, physical activity and laparoscopic sleeve gastrectomy. Physical Res.2014, 63(2), 207-218.Search in Google Scholar

21. Friedewal, W.; Levy, R.; Fredrickson, D. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of preparative ultracentrifuge. Clin. Chem.1972, 18(6), 499-502.Search in Google Scholar

22. Mattews, D.; Hosker, J.; Rudenski, A.; Naylor, B.; Treacher, D.; Turner, R. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia1985, 28(7), 412-419.Search in Google Scholar

23. Senthilkumar, G.; Anithalekshmi, M.; Yasir, M.; Parameswaran, S.; Packirisamy, R.; Bobb, Z. Role of omentin-1 and 1L-6 in type2 diabetes mellitus patients with diabetic nephrophathy. Diabetes Metab. Syndrome Clin. Res. Rev. 2018, 12(1), 23-26.Search in Google Scholar

24. Pan, H.; Guo, L.; Li, Q. Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes. Diabetes Res. Clin. Pract. 2010, 88(1), 29-33.Search in Google Scholar

25. Catoi, A.; Suelu, S.; Parvu, A.; Copaescu, C.; Galea, R.; Buzoianu, A.; Vereşiu, I.; Cătoi, C.; Pop, I. Increased chimera and decreased omentin-1 levels in morbidly obese patients are correlated with insulin resistance, oxidative stress and chronic inflammation. Clujul Med., 2014, 87(1), 19-26.Search in Google Scholar

26. Moreno-Navarrele, J.; Ortega Gastro, A.; Sabater, M.; Ricart, W.; Fernández-Real, J. Circulating omentin as a novel biomarker of endothelial dysfunction. Obesity2011, 19(8), 1552-1559.Search in Google Scholar

27. El-Mesallamy, H.; El-Derany, M.; Hamdy, N. Serum omentin-1 and chemerin levels are interrelated in patients with type 2 diabetes mellitus with or without ischaemic heart disease. Diabet. Med. 2011, 28(10), 194-200.Search in Google Scholar

28. Yang, R. Z.; Lee, M. J.; Hu, H. B.; Pray, J.; Wu, H.; McLenithan, J. C.; Gong, D. W. Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating. Am. J. Physiol. Endocrinol. Metab. 2006, 290(6), 1253-1261.Search in Google Scholar

29. Hernandez-Diaz, A.; Arana-Martinez J. C.; Carbo, R.; Espinosa-Cervantes, R.; Sánchez-Muñoz F. Omentin: Role in insulin resistance, inflammation and cardiovascular protection. Arch. Cardiol. Met. 2016, 86(3), 233-243.Search in Google Scholar

30. Akour, A.; Kasabri, V.; Boulatova, N.; Bustanji, Y.; Naffa, R.; Hyasat, D.; Khawaja, N.; Bustanji, H.; Zayed, A.; Momani, M. Levels of metabolic markers in drug-naive prediabetic and type 2 diabetic patients. Acta Diabetol. 2017, 54(2), 163-170.Search in Google Scholar

31. Guo, L.; Jiang, T.; Liu, H.; He, H. Relationship between serum omentin-1 level and bone mineral density in girls with anorexia nervosa. J. Endocrinol. Invest. 2013, 36(3), 190-194.Search in Google Scholar

32. Bougle, D.; Bureau, F.; Laroche, D. Trace element status in obese chidren: Relationship with metabolic risk factor. E SPEN Eur. E J. Clin. Nutr. Metab. 2009, 4(2), 98-100.Search in Google Scholar

33. Kazi, T.; Afridi, H.; Kazi, N.; Jamali, M.; Arain, M.; Jalbani, N. Copper, Chromium, Manganese, Iron, Nickel, and Zinc level in biological samples of diabetes mellitus patients. Biol. Trace Res. 2008, 122(1), 1-18.Search in Google Scholar

34. Mikhail, N. The metabolic syndrome: Insulin resistance. Curr. Hypertens. Rep. 2009, 156-158.Search in Google Scholar

35. Farasani, G.; Targhi, F.; Pishgahroudsari, M.; Mokhber, S.; Pazouki, A. High prevelance of zinc deficiency in Iranian morbid obese patients undergoing bariatric surgery. J. Minim. Invasive Surg. Sci. 2015, 4(3), 334-336.Search in Google Scholar

36. Zavala, G.; Long, K. Z.; Garcia, O. P.; Caamano, M.; Aguilar, T.; Salgado, L. M.; Rosado, J. L. Specific micronutrient concentrations are associate with inflammatory cytokines in a rural population of Mexican women with a high prevalence of obesity. Brit. J. Nutr. 2012, 109(4), 1-9.Search in Google Scholar

37. Kelishadi, R.; Hashemipour, M.; Adeli, K.; Tavakoli, N.; Movahedian-Attar, A.; Shapouri, J.; Rouzbahani, A. Effect of zinc supplementation on markers of insulin resistance, oxidative stress, and inflammation syndrome. Metab. Syndr. Relat. D.2010, 8(6), 505-510.Search in Google Scholar

38. Azab, S.; Saleh, S.; Elsaeed, W.; Elshafie, M.; Sherief, L.; Esh, A. Serum trace elements in obese Egyptian children: A case-control study. Ital. J. Pediatr. 2014, 40, 2-7.Search in Google Scholar

39. Zittermann, A.; Emst, J.; Gumment, J. Vitamin D supplementation, body weight and human serum 25-hydroxyvitamin D response: a systematic review. Eur. Nutr.2014, 53(2), 367-374.Search in Google Scholar

40. Menzie, C. M.; Yanoff, L. B.; Denkinger, B. I.; McHugh, T.; Sebring, N..; Calis, K. A.; Yanovski, J. A. Obesity-related hypoferremia is not explained by differences in reported intake of heme and non heme iron or intake of dietary factors that affect iron absorption. J. Am. Diet. Assoc. 2008, 108(1), 145-148.Search in Google Scholar

Recommended articles from Trend MD

Plan your remote conference with Sciendo